Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Yucan Granules for microalbuminuria in diabetic kidney disease
CTR20253579Phase 2Active
- Sponsor
- Humanwell Innovative Drug R&D Center
- Start
- Sep 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yucan granules in diabetic glomerulosclerosis, sponsored by Humanwell Innovative Drug R&D Center. Started Sep 2025; status: active.
02
Drugs
Yucan granules
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on CTR20253579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253579.